Council for Tobacco Research
Annual Report of the Scientific Director [St]
Abstract
MAR
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00000667-6967
Related Documents:- CTRMN000667-0808 Deposition of Robert F. Gertenbach [Deposition of Gertenbach in the Matter of Rogers]
- CTRMN000809-0827 Certificate of Incorporation of the Council for Tobacco Research - U.S.A., Inc. Under Section 402 of the Not-for-Profit Corporation Law [Details Definitions and Purposes for Forming A Not-for-Profit Corporation]
- CTRMN000828-0848 by-Laws of the Council for Tobacco Research - U.S.A., Inc. [Rules and Regulations for the Operation of the Council]
- CTRMN000849-0854 Application for Research Grant [A Blank Funding Request Form for Scientific Studies]
- CTRMN000855-0856 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Stipulations for Receiving A Funding Award]
- CTRMN000857-0859 [Suggestions and Guidelines for Submitting A Request for A Grant]
- CTRMN000860-0871 [Transmittal of Information for Securing A Research Grant]
- CTRMN000872-0882 [A Blank Funding Request Form for Scientific Studies]
- CTRMN000883-0892 Closing Dates for Application of Renewal Grants Requirements: (1) Progress Report and (2) Abstract of Progress Report [Procedural Information for Applying for Continued Funding for Scientific Project]
- CTRMN000893-1031 Published Reports on Research Supported in Whole or in Part by the Council for Tobacco Research - U.S.A. Formerly the Tobacco Industry Research Committee [List of Scientific Studies]
- CTRMN001032-1045 1956 Report of the Scientific Director [St]
- CTRMN001046-1094 1957 Report of the Scientific Director [St]
- CTRMN001095-1127 1958 Report of the Scientific Director [St]
- CTRMN001128-1163 1959 Report of the Scientific Director [St]
- CTRMN001164-1201 1960 Report of the Scientific Director [St]
- CTRMN001202-1239 1961 Report of the Scientific Director [St]
- CTRMN001240-1269 1962 Report of the Scientific Director [St]
- CTRMN001270-1306 Annual Report of the Scientific Director [St]
- CTRMN001307-1346 Report of the Scientific Director [St]
- CTRMN001347-1387 Report of the Scientific Director [St]
- CTRMN001388-1429 Report of the Scientific Director [St]
- CTRMN001486-1529 Report of the Scientific Director [St]
- CTRMN001530-1578 Annual Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001579-1632 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001633-1681 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001682-1727 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001728-1771 1975 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001772-1816 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001817-1860 1977 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001861-1913 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001914-1967 1979 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN001968-2025 1980 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002026-2088 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002089-2148 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002149-2223 Report of the Council for Tobacco Research-U.S.A., Inc. [St]
- CTRMN002224-2942 Application for Research Grant An Investigation of the Spectral and Chromatographic Characteristics of Aromatic Hydrocarbons. [Study on High Temperature Gas-Liquid Partition Chromatography]
- CTRMN002943-3303 [Regarding Polio and Tuberculosis As Predisposing Factor in Lung Cancer]
- CTRMN003304-3322 Tobacco-Health Research Program [Display Case Showing Main Areas of Investigation]
- CTRMN003323-3326 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Rules for Approval of Grants Relating to Tobacco Use and Human Health]
- CTRMN003327-3337 A Brief Review of the Smoking-Lung Cancer Theory [Concerning Problems of Cigarette Lung Cancer Causation and Why They Have No Been Solved]
- CTRMN003338-3357 A Scientific Perspective on the Cigarette Controversy [Views of Cancer Experts on Causes of Lung Cancer]
- CTRMN003358-3365 Some Information About... The Council for Tobacco Research-U.S.A., Inc. ...and Its Research Program [Informs About the Purpose and Function of Organization's Research Program]
- CTRMN003366-3374 the Research Program of the Scientific Advisory Board to the Council for Tobacco Research - U.S.A. [Informs the Purposes, Policies, and the Research Program of the Board]
- CTRMN003375-3419 the Cancer-Smoking Controversy [Regards the Fallacious Conclusions of Cigarette Smoking Causing Lung Cancer From A Mathematical and Scientific Point of View]
- CTRMN003420-3425 Some Harvard Men & the Smoking Habit [Give Results of Questionnaire Relating to Biological Factors of Tobacco Smoking]
- CTRMN003426-3431 the Pathologic Anatomy of the Bronchial Tree and Lungs Reprinted From the Archives of Pathology Vol. 70 [St Finds of Equivocal Results with the Use of Tobacco]
- CTRMN003432-3437 Some Statistical Observations on A Co-Operative Study of Human Pulmonary Pathology Reprinted From the Proceedings of the National Academy of Sciences Vol. 43 No. 12 [St Examines Systematically the Conditions at Autopsy in the Bronchial Mucosae of Random Cases]
- CTRMN003438-3442 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology, II [Results Show Pathological Lungs in Different Cities Are Acutally Different]
- CTRMN003443-3447 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology. II [Study Comparing Pathological Conditions in 8 Different Cities Shows That Conditions Are All Different]
- CTRMN003448-3456 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology [Systematic Examinations of the Conditions at Autopsy in the Bronchial Mucosae of Run-of-the-Mill Cases]
- CTRMN003457-3464 Some Statistical Observations on A Cooperative Study of Human Pulmonary Pathology III [When Probability Is Doubtful the Use of Variable Tables to Calculate Results Is the Best Way to Make A Precise and Accurate Answer for Sufficient Range of Pathological Conditions]
- CTRMN003465-3476 Differences Between Smokers and Nonsmokers [Differences Between Smokers and Nonsmokers Have to Do with Personality Traits and Physiologic Criteria]
- CTRMN003477-3485 the Psychology of Smoking [Smoking Is Determined by Certain Personality Variables and Personal Needs]
- CTRMN003486-3490 the Tobacco and Health Research Program of the Scientific Advisory Board [Regarding Information the Tobacco Industry Research Committee Do for the Research Program]
- CTRMN003491-3558 Tobacco Consumption in Various Countries [Results of Cigarette and Cigar Smokers From Different Countries]
- CTRMN003559-3560 Statement of Policy Containing Conditions and Terms Under Which Project Grants Are Made [Guidelines for Which Grants Are Approved]
- CTRMN003561-3780 Tobacco Smoking in the United States in Relation to Income Marketing Research Report No. 189 [A Report Compiled by the Bureau of the Census for the United States Public Health Service on Smoking Characteristics in Relation to Income, Age, Region, Urban-Rural Residence and Occupation.]
- CTRMN003781-3781 Operating Results 1982 and Budget 1983 [Record of Expenditures]
- CTRMN003782-3782 Operating Results for Ten-Months Ended 10/31 Budget 11/1/83 Through 10/31/84 [Record of Expenditures]
- CTRMN003783-3783 Actual Operating Fiscal Year 1984 and Budget Fiscal Year 1985 [Record of Expenditures]
- CTRMN003784-3787 Confidential Report on Meeting January 18, 1954 Tobacco Industry Research Committee (TIRC) [St]
- CTRMN003788-3797 Confidential Report on Meeting March 15, 1954 Tobacco Industry Research Committee [St]
- CTRMN003798-3800 Tobacco Industry Research Committee Meeting [St]
- CTRMN003801-3815 Tobacco Industry Research Committee Meeting [St]
- CTRMN003816-3835 Tobacco Industry Research Committee Meeting [St]
- CTRMN003836-3852 Tobacco Industry Research Committee Meeting November 3, 1955 [St]
- CTRMN003853-3869 Tobacco Industry Research Committee Meeting February 14, 1956 [St]
- CTRMN003870-3895 Tobacco Industry Research Committee Meeting October 9, 1956 [St]
- CTRMN003896-3907 Tobacco Industry Research Committee Meeting May 9, 1957 [St]
- CTRMN003908-3923 Tobacco Industry Research Committee Meeting November 8, 1957 [St]
- CTRMN003924-3931 Tobacco Industry Research Committee Meeting May 8 1958 [St]
- CTRMN003932-3939 Tobacco Industry Research Committee Meeting November 6, 1958 [St]
- CTRMN003940-3945 Tobacco Industry Research Committee Meeting [St]
- CTRMN003946-3956 Tobacco Industry Research Committee Meeting December 10, 1959 [St]
- CTRMN003957-3969 Tobacco Industry Research Committee Meeting November 15, 1960 [St]
- CTRMN003970-3982 Tobacco Industry Research Committee Meeting October 18, 1961 [St]
- CTRMN003983-3991 Tobacco Industry Research Committee Meeting [St]
- CTRMN003992-4002 Tobacco Industry Research Committee Meeting November 15, 1962 [St]
- CTRMN004003-4006 the Council for Tobacco Research - U.S.A. March 5, 1964 [St]
- CTRMN004007-4014 the Council for Tobacco Research - U.S.A. June 8, 1965 [St]
- CTRMN004015-4020 the Council for Tobacco Research - U.S.A. January 27, 1967 [St]
- CTRMN004021-4026 the Council for Tobacco Research - U.S.A. January 24, 1968 [St]
- CTRMN004027-4034 the Council for Tobacco Research - U.S.A. January 31, 1969 [St]
- CTRMN004035-4041 Minutes of the First Meeting of the Board of Directors [St]
- CTRMN004042-4048 Minutes of the Second Meeting of the Board of Directors January 29, 1971 [St]
- CTRMN004049-4052 Minutes of the Meeting of the Executive Committee of the Board of Directors June 24, 1971 [St]
- CTRMN004053-4057 Minutes of of the Board of Directors January 28, 1972 [St]
- CTRMN004058-4061 Minutes of the Meeting of the Board of Directors November 10, 1972 [St]
- CTRMN004062-4066 Minutes of the Meeting of the Board of Directors January 26, 1973 [St]
- CTRMN004067-4070 Minutes of the Special Meeting of the Board of Directors July 26, 1973 [St]
- CTRMN004071-4076 Minutes of the Meeting of the Board of Directors February 1, 1974 [St]
- CTRMN004077-4081 Minutes of the Special Meeting of the Board of Directors June 13, 1974 [St]
- CTRMN004082-4086 Minutes of the Special Meeting of the Board of Directors December 5, 1974 [St]
- CTRMN004087-4091 Minutes of the Meeting of the Board of Directors January 31, 1975 [St]
- CTRMN004092-4095 Minutes of the Special Meeting of the Board of Directors July 24, 1975 [St]
- CTRMN004096-4141 Retirement Plan for Employees of the Council for Tobacco Research - U.S.A., Inc. Amended and Restated As of July 1, 1975 [St]
- CTRMN004142-4147 Minutes of the Special Meeting of the Board of Directors December 10, 1975 [St]
- CTRMN004148-4153 Minutes of the Meeting of the Board of Directors January 30, 1976 [St]
- CTRMN004154-4157 Minutes of the Special Meeting of the Board of Directors September 9, 1976 [St]
- CTRMN004158-4161 Minutes of the Meeting of the Board of Directors January 28 1977 [St]
- CTRMN004162-4166 Minutes of the Special Meeting of the Board of Directors April 21 1978 [St]
- CTRMN004167-4167 Minutes of the Special Meeting of the Executive Committee of the Board of Directors August 17, 1978 [St]
- CTRMN004168-4172 Minutes of the Meeting of the Board of Directors January 29, 1979 [St]
- CTRMN004173-4176 Minutes of the Meeting of the Board of Directors February 1, 1980 [St]
- CTRMN004177-4178 Minutes of the Board of Directors Executive Committee Meeting New York, New York [St]
- CTRMN004179-4184 Minutes of the Meeting of the Directors January 30, 1981 [St]
- CTRMN004185-4189 Minutes of the Special Meeting of the Board of Directors June 25, 1981 [St]
- CTRMN004190-4192 Minutes of A Meeting of Certain Members of the Board of Directors [St]
- CTRMN004193-4198 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004199-4205 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004206-4209 Minutes of the Meeting of the Board of Directors [St]
- CTRMN004210-4213 Minutes of the Special Meeting of the Board of Directors [St]
- CTRMN004214-4217 Confidential Report of Scientific Advisory Board Meeting [St]
- CTRMN004218-4221 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004222-4226 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004227-4232 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004233-4236 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004237-4240 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004241-4246 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004247-4251 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004252-4256 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004257-4266 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004267-4283 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004284-4287 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004288-4292 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004293-4297 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004298-4303 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004304-4310 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004311-4316 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004317-4319 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004320-4323 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004324-4330 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004331-4335 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004336-4339 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004340-4344 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004345-4348 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004349-4353 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004354-4357 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004358-4366 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004367-4370 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004371-4376 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004377-4390 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004391-4395 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004396-4400 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004401-4404 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004405-4409 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004410-4413 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004414-4416 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004417-4420 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004421-4426 Confidential Report Scientific Board Meeting [St]
- CTRMN004427-4430 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004431-4433 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004434-4436 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004437-4439 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004440-4443 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004444-4446 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004447-4450 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004451-4454 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004455-4459 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004460-4463 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004464-4467 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004468-4472 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004473-4475 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004476-4480 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004481-4484 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004485-4492 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004493-4497 Confidential Report Scientific Advisory Board Meeting September 23-24, 1967 [St]
- CTRMN004498-4501 Confidential Report Scientific Advisory Board Meeting December 9-10, 1967 [St]
- CTRMN004502-4505 Confidential Report Scientific Advisory Board Meeting [St]
- CTRMN004506-4510 Confidential Report Scientific Advisory Board Meeting La Jolla, California March 2-3-4, 1968 [St]
- CTRMN004511-4516 Confidential Report Scientific Advisory Board Meeting New York New York May 25-26, 1968 [St]
- CTRMN004517-4522 Confidential Report Scientific Advisory Board Meeting New York, New York September 14-15, 1968 [St]
- CTRMN004523-4526 Confidential Report Scientific Advisory Board Meeting New York, New York December 8-9, 1968 [St]
- CTRMN004527-4531 Confidential Report Scientific Advisory Board Meeting New York, New York March 22-23, 1969 [St]
- CTRMN004532-4538 Confidential Report Scientific Advisory Board Meeting New York, New York May 16-18, 1969 [St]
- CTRMN004539-4544 Confidential Report Scientific Advisory Board Meeting New York, New York September 12-14, 1969 [St]
- CTRMN004545-4549 Confidential Report Scientific Advisory Board Meeting New York, New York December 12-14, 1969 [St]
- CTRMN004550-4555 Confidential Report Scientific Advisory Board Meeting Colorado Springs, Colorado March 20-22, 1970 [St]
- CTRMN004556-4560 Confidential Report Scientific Advisory Board Meeting New York, New York [St]
- CTRMN004561-4569 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 18-19-20, 1970 [St]
- CTRMN004570-4578 Confidential Report Scientific Advisory Board Meeting Chicago, Illinois January 15,16, 1971 [St]
- CTRMN004579-4585 Confidential Report Scientific Advisory Board Meeting New York, N.Y. May 7-8-9, 1971 [St]
- CTRMN004586-4593 Confidential Report Scientific Advisory Board Meeting New York, N.Y. September 24-25-26, 1971 [St]
- CTRMN004594-4598 Confidential Report Scientific Advisory Board Meeting New York, N.Y. [St]
- CTRMN004599-4604 Confidential Report Scientific Advisory Board Meeting Palm Springs, California March 24-25-26, 1972 [St]
- CTRMN004605-4609 Confidential Report Scientific Advisory Board Meeting New York, New York June 9-11, 1972 [St]
- CTRMN004610-4614 Confidential Report Scientific Advisory Board Meeting New York, New York September 15-17, 1972 [St]
- CTRMN004615-4623 Confidential Report Scientific Advisory Board Meeting New York, New York March 14-15-16, 1973 [St]
- CTRMN004624-4626 Meeting Executive Committee of the Scientific Advisory Board June 13, 1973 New York, N.Y. [St]
- CTRMN004627-4634 Confidential Report Scientific Advisory Board Meeting New York, New York October 10-11-12, 1973 [St]
- CTRMN004635-4643 Meeting Executive Committee of the Scientific Advisory Board December 4, 1973 New York, N.Y. [St]
- CTRMN004644-4654 Confidential Report Scientific Advisory Board Meeting New York, New York October 30-31 November 1, 1974 [St]
- CTRMN004655-4656 Meeting Executive Committee of the Scientific Advisory Board December 13, 1974 New York, N.Y. [St]
- CTRMN004657-4664 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 26-27-28, 1975 [St]
- CTRMN004665-4672 Confidential Report Scientific Advisory Board Meeting New York, New York September 10-11-12, 1975 [St]
- CTRMN004673-4675 Meeting Executive Committee of the Scientific Advisory Board New York, New York December 13, 1975 [St]
- CTRMN004676-4683 Confidential Report Scientific Advisory Board Meeting Santa Barbara, California March 17-18-19, 1976 [St]
- CTRMN004684-4686 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 11, 1976 [St]
- CTRMN004687-4694 Confidential Report Scientific Advisory Board Meeting New York, New York September 28-29-30, 1976 October 1, 1976 [St]
- CTRMN004695-4697 Meeting of the Executive Committee of the Scientific Advisory Board Bethesda, Maryland December 1, 1976 [St]
- CTRMN004698-4706 Confidential Report Scientific Advisory Board Meeting Tuscon, Arizona March 23-25, 1977 [St]
- CTRMN004707-4708 Meeting of the Executive Committee of the Scientific Advisory Board Tuscon, Arizona March 25, 1977 [St]
- CTRMN004709-4710 Meeting of the Executive Committee of the Scientific Advisory Board New York, New York May 19, 1977 [St]
- CTRMN004711-4719 Confidential Report Scientific Advisory Board Meeting New York, New York October 26-28, 1977 [St]
- CTRMN004720-4723 Confidential Report Scientific Advisory Board Meeting Phoenix, Arizona January 16-17, 1978 [St]
- CTRMN004724-4724 Confidential Report Meeting of the Scientific Advisory Board Committee Phoenix, Arizona January 17, 1978 [St]
- CTRMN004725-4734 Confidential Report Scientific Advisory Board Meeting New York, New York April 26-27-28, 1978 [St]
- CTRMN004735-4735 Confidential Report Scientific Advisory Board Executive Committee New York, New York April 27, 1978 [St]
- CTRMN004736-4737 Confidential Report Meeting for the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004736A-4736A Confidential Report Meeting of the Scientific Advisory Board New York, New York July 27, 1978 [St]
- CTRMN004738-4747 Confidential Report Scientific Advisory Board Meeting New York, New York October 18-19-20, 1978 [St]
- CTRMN004748-4750 Confidential Report Meeting of the Scientific Advisory Board New York, New York December 20, 1978 [St]
- CTRMN004751-4759 Confidential Report Scientific Advisory Board Meeting New York, New York April 11-12-13, 1979 [St]
- CTRMN004760-4769 Confidential Report Scientific Advisory Board Meeting New York, New York October 17-18-19, 1979 [St]
- CTRMN004770-4770 Confidential Meeting of the Report Scientific Advisory Board New York, New York October 18, 1979 [St]
- CTRMN004771-4780 Confidential Report Scientific Advisory Meeting New York, New York Aprill 9-10-11, 1980 [St]
- CTRMN004781-4781 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York June 20, 1980 [St]
- CTRMN004782-4783 Confidential Report Executive Committee of the Scientific Advisory Board Meeting New York, New York September 16, 1980 [St]
- CTRMN004784-4792 Confidential Report Scientific Advisory Board Meeting New York, New York October 8-9-10, 1980 [St]
- CTRMN004793-4794 Confidential Report Meeting of the Scientific Advisory Board New York, New York October 9, 1980 [St]
- CTRMN004795-4804 Confidential Report Scientific Advisory Board Meeting New York, New York April 8-9-10, 1981 [St]
- CTRMN004805-4805 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 8, 1981 [St]
- CTRMN004806-4806 Confidential Report Meeting of the Scientific Advisory Board New York, New York September 10, 1981 [St]
- CTRMN004807-4816 Confidential Report Scientific Advisory Board Meeting New York, New York October 14-15-16, 1981 [St]
- CTRMN004817-4818 Confidential Report Meeting of the Executive Committee Scientific Advisory Board New York, New York October 15, 1981 [St]
- CTRMN004819-4820 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York December 9, 1981 [St]
- CTRMN004821-4831 Confidential Report Scientific Advisory Board Meeting New York, New York April 21, 22, 23, 1982 [St]
- CTRMN004832-4833 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 21, 1982 [St]
- CTRMN004834-4843 Confidential Report Scientific Advisory Board Meeting New York, New York October 6,7,8, 1982 [St]
- CTRMN004844-4844 Confidential Report Meeting of the Executive Meeting of the Scientific Advisory Board New York, New York October 8, 1982 [St]
- CTRMN004845-4845 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Scottsdale, Arizona February 24, 1983 [St]
- CTRMN004846-4857 Confidential Report Scientific Advisory Board Meeting New York, New York April 20, 21, 22, 1983 [St]
- CTRMN004858-4858 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 22, 1983 [St]
- CTRMN004859-4859 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York June 6, 1983 [St]
- CTRMN004860-4871 Confidential Report Scientific Advisory Board Meeting New York, New York October 12, 13, 14, 1983 [St]
- CTRMN004872-4882 Confidential Report Scientific Advisory Board Meeting New York, New York March 28, 29, 30, 1984 [St]
- CTRMN004883-4883 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York March 29, 1984 [St]
- CTRMN004884-4895 Confidential Report Scientific Advisory Board Meeting September 19, 20, 21, 1984 New York, New York [St]
- CTRMN004896-4896 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York September 20, 1984 [St]
- CTRMN004897-4897 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board Palm Beach, Florida February 25, 1985 [St]
- CTRMN004898-4898 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004899-4910 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004911-4911 Confidential Report Meeting of the Executive Committee of the Scientific Advisory Board New York, New York April 16, 1985 [St]
- CTRMN004912-4923 Confidential Report Scientific Advisory Board Meeting April 15, 16, 17, 1985 New York, New York [St]
- CTRMN004924-4927 for Release: A.M.'s Wednesday, April 14, 1954 ["Reaction to the Compendium "A Scientific Perspective on the Cigarette Controversy""]
- CTRMN004928-4929 for Release: A.M.'s Tuesday, April 27, 1954 [Scientific Advisory Board Organized Early to Begin Research Into All Phases of Tobacco Use and Health for the Year]
- CTRMN004930-4931 for Release in A.M.'s of Tuesday, May 18, 1954 [Proposals Submitted for Cancer Research Projects for Consideration by Scientific Advisory Board]
- CTRMN004932-4933 for Release After 10:30 A.M., June 15, 1954 [Appointment of Dr. Clarence Cook Little Announced by the Tobacco Research Industry Committee]
- CTRMN004934-4937 for Immediate Release [American Cancer Society Survey Conveys the Need to Further Research to Discover Cause of Cancer and Cardiovascular Disease]
- CTRMN004938-4939 for Release in Am's of Tuesday, July 20, 1954 [Edwin B. Wilson of Harvard University Became A Member of Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004940-4942 for Release: A.M.'s of Wednesday, July 28, 1954 Little Announces Research Policy of Tobacco Industry Research Committee [Three Main Areas to Be Covered by Research Program Announced]
- CTRMN004943-4944 for Release in A.M.'s Thursday, August 19, 1954 [Dr. Julius H. Comroe of University of Pennsylvania, Accepted Membership on Scientific Advisory Board of the Tobacco Industry Research Committee]
- CTRMN004945-4945 for Immediate Release (Monday, October 11, 1954) Dr. Little Gives TIRC View [Little States That No Convincing Evidence Has Yet Been Found to Prove That Cigarette Smoking Causes Lung Cancer]
- CTRMN004946-4946 for Immediate Release (Tuesday, October 12, 1954) [Timothy V. Hartnet, Chairman of Board, Stated That Public Should Be Reminded That No Lung Cancer Causing Agent Has Yet Been Identified in Tobacco]
- CTRMN004947-4947 for Release: Wednesday, October 20, 1954 Hartnett Approves Care in Research [Committee to Be Sure That Reliable Evidence Is Available Before Announcing Important Conclusions to the Public About Smoking]
- CTRMN004948-4948 for Immediate Release (Thursday, October 21, 1954) Hartnett Comments on Cigarette Paper Burning [Timothy V. Hartnett Comments That A Cancer Causing Compound on Skin of Mice Has Been Produced by Burning Cigarette Paper Under Certain Lab Conditions]
- CTRMN004949-4952 for Release: A.M.'s, Monday, November 8, 1954 Tobacco Industry Research Committee Announces Initial Grants [Six Scientific Research Grants Totalling Over $82,000 Made Public]
- CTRMN004953-4954 for Release in A.M.'s, Monday, December 6, 1954 Scientific Associate Named by Tobacco Research Group [Robert C. Hockett Appointed As Scientific Director of TIRC to Help Develop Research Into Tobacco Use and Health]
- CTRMN004955-4956 for Immediate Release Cross-Country Lung Study Planned by Tobacco Group [Group of Pathologists Plan A Cooperative Study to Increase Knowledge of Lung Ailments]
- CTRMN004957-4959 for Release in Year-End Editions But Not Before December 27, 1954 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [TIRC Will Approve A Quarter of A Million Dollars for Research Into Public Health Problems by the End of 1954]
- CTRMN004960-4963 for Release: Monday A.M.'s, January 17, 1955 Tobacco Industry's New Research Grants Send Total to More Than $300,000 [New Research Grants Announced by TIRC to Relate to Both Human and Animal Scientific Studies]
- CTRMN004964-4966 for Release in A.M.'s of Friday, April 8, 1955 Tobacco Industry Group Votes Medical Research Fellowships [TIRC Announced Fellowship Program to Create Interest in Research Among Medical School Students]
- CTRMN004967-4969 Release Tuesday, May 17, 1955 and Thereafter Tobacco and Health Studies Cover Wide Range of Research [Although No Scientific Proof That Cigarettes or Air Pollution Cause Lung Cancer, Progress Is Being Made to Learn More About Tobacco Use and Health by the TIRC]
- CTRMN004970-4972 Tobacco Research Grants Increased to 490,000 Mark [Research Grants Are Created So Science Can Provide An Answer to Public Health Problems]
- CTRMN004973-4973 Hartnett Comments on Auerbach Paper [Many Studies on Human Lung Tissue, Not Enough Data Available to Draw A Conclusion Yet]
- CTRMN004974-4975 Anti-Smoking Theories Not Based on Complete Scientific Knowledge [Scientific Investigation Into What the Real Effects Are From Tobacco Use]
- CTRMN004976-4977 Hartnett Comments on Statistical Study [Research Intensified in Past Year, No Proof That Smoking Causes Cancer]
- CTRMN004978-4980 Doctor's Survey Termed 'biased, 'says Hartnett [Questionnaire Would Give No Concrete Conclusions About Tobacco Causing Cancer]
- CTRMN004981-4982 Hartnett Alerts Burley Men to Challenge Tobacco Attacks [Doctors Are Expressing Their Doubts About Statements Already Made; Tobacco Effects]
- CTRMN004983-4984 Bright Belt Warehouse Men Told Facts Challenge Critics [Still Looking for Proof That Tobacco Causes Cancer]
- CTRMN004985-4986 Tobacco Spokesman Says Facts and Position Are Unchanged [Various Experiments with Animals Showed That Cancer Was Not the Outcome From Tobacco Smoke]
- CTRMN004987-4987 Hartnett Comments on Statistical Study [Methods Used for Cancer Research Still Do Not Give Enough Information]
- CTRMN004988-4990 British Tobacco Experiments Unable to Induce Cancers [Still No Connection, Tests Will Continue]
- CTRMN004991-4993 Tobacco Research Grants Now Over 838,000 Mark [Tobacco Research Is Getting More Support From Doctors, Scientists, and Educators]
- CTRMN004994-4996 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Summary of the Past Years' Events in Tobacco Research]
- CTRMN004997-4999 Tobacco Research Fund Raised to 1,500,000 [Finding New Ways to Break Down Tobacco]
- CTRMN005000-5001 Tobacco Industry Group Renews Medical Research Fellowships [More Medical Students Are Receiving Fellowships Than Last Year]
- CTRMN005002-5003 Hartnett Statement on Cancer Meeting Reports [There Is Still Much Research to Be Done Before Tobacco Is Linked to Cancer]
- CTRMN005004-5005 [Pathologists From Around the Country Have Studied Human Lung Tissues Over the Past Year]
- CTRMN005006-5006 [Smoking Patterns Do Not Explain Differences in Lung Cancer]
- CTRMN005007-5008 Hartnett Cites British Tobacco Tests Failing to Produce Animal Cancer [the Search for Cancer Must Be Broadened and Intensified]
- CTRMN005009-5010 Hartnett Comments on Statistical Claims [Although Many Believe Smoking Causes Cancer, Scientists Still Have Not Found Any Prof]
- CTRMN005011-5011 [Present Knowledge Doesn't Hint A Relationship Between Smoking and Heart Problems]
- CTRMN005012-5016 Hartnett Comments on Cancer Society Booklet [Pamphlet Omits Some Important Research Results]
- CTRMN005017-5018 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Research Committee Needs More Scientific Investigation]
- CTRMN005019-5025 Tobacco Research Funds Reach 2.2 Million Mark [Over 60 Independent Scientists Throughout the Country Are Working in Institutions to Further the Research of Cancer and Tobacco Use, They Are Listed]
- CTRMN005026-5027 Hartnett Comments on French Report [French Are Reporting Rapid Cancer Formation in Mice, Hartnett Feels It Can't Be Judged on the Basis of New Reports Without Longer Consideration and Careful Analysis]
- CTRMN005028-5030 Harnett Cites Points for Clarification in Tobacco Health Study [Smoking Study Reached the Public's Attention Before It Was Reviewed and Before the Facts Were Made Crystal Clear]
- CTRMN005031-5032 Hartnett Comments on Wynder News Stories [News Story Claims That Assumptions Have Been Made About Mouse Skin Painting Experiments]
- CTRMN005033-5037 Statement on Smoking and Health Studies [Scientists Are Developing A Program for Different Phases of Tobacco Use and Health, Members Listed]
- CTRMN005038-5045 Hartnett Says Statistics Do Not Establish Causes [Studies Are Open to Assumptions and Certain Selection of Subjects]
- CTRMN005046-5048 Hartnett Cites Scientists Doubting Smoking-Cancer Theory [the Surgeon General Believes the Studies Are Missing Essential Facts That Should Be Acknowledged]
- CTRMN005049-5050 Scientist Comments on Benzpyrene Report [Benzpyrane in Tobacco Smoke, Under Investigation for Years Caused Cancer in Lab Animals But Not Humans]
- CTRMN005051-5055 "Cancer Researcher Challenges "Cause and Effect" Charges Against Smoking" [It's Difficult to Have A Cause and Effect Relationship When Dealing with Cancer and Tobacco Use]
- CTRMN005056-5056 [Atlantic Monthly Gives A Misleading Picture of Dr. Little and His Public Position]
- CTRMN005057-5058 Tobacco Committee Chairman Comments on Cancer Society Talk [Many Unresolved Questions About Tobacco Causing Cancer Don't Stop Researching]
- CTRMN005059-5061 Tobacco Research Scientist Discusses Smoking Question [Most Tend to Believe the Anti-Cigarette Theory But It Shouldn't Be Confused with the Facts There's Still Not Enough Facts to Prove That Smoking Causes Cancer]
- CTRMN005062-5062 Hartnett Says Leaflet Admits Differing Opinions on Smoking [Leaflet Tells How Scientists Disagree on Evidence]
- CTRMN005063-5066 Research Program Throws Doubts on Smoking Charges [Incorrect Claims and Harmful Effects From Tobacco]
- CTRMN005067-5069 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [More and More Scientists Had Doubts and Disbeliefs in the Charges Against Smoking As A Cause of Cancer]
- CTRMN005070-5071 Tobacco Research Scientist Discusses Smoking Question [Scientists Say Smoking Has Been Proved Guilty When Linked with Human Health Problems]
- CTRMN005072-5072 Pamphlet Merely Review, Dr. Little Says [Opinions Is All the Author Gives in His Pamphlet Scientists Are Still Disputing]
- CTRMN005073-5076 TIRC Fund for Research Boosted to $2,700,000 [Grants for Independent Scientists Interested in Studying Problems of Cancer and Heart Disease When Related to Smoking]
- CTRMN005077-5080 [New Knowledge on Smoking and Health Questions]
- CTRMN005081-5081 [Veterans Study of Smoking Habits]
- CTRMN005082-5082 [Report on How There Was Existing Research Evidence and How It Was Ignored]
- CTRMN005083-5085 [Regarding Anti-Tobacco Movement]
- CTRMN005086-5086 [Benzpyrene in Cigarette Smoke]
- CTRMN005087-5088 [Experimental Evidence Is Weak]
- CTRMN005089-5089 Hartnett Says Article on Arsenic Goes Beyond Facts [Farmers Use of Insecticides with Arsenicals on Growing Tobacco Has Steadily Been Declining]
- CTRMN005090-5091 [Scientists Who Produce Conflicting Results Are Being Ignored by the Health Department]
- CTRMN005092-5094 Statement by Timothy V. Hartnett, Chairman Tobacco Industry Research Committee [Even More Grants Have Been Made Available More Factors Have Been Associated with Lung Cancer]
- CTRMN005095-5100 Tobacco Industry Group Announces Research Grants [Grant Increases to $3,200,000 List of Grants Announced]
- CTRMN005101-5103 Tobacco-Health Research Described in 1958 Report [the Report Talked About Experiments That Were Unable to Produce Cancer and the Cause and Effect Theory]
- CTRMN005104-5104 [Report Shows That Other Factors Besides Smoking Have Been Causing Lung Cancer, But Scientists Do Not Dismiss the Fact That Lung Cancer Is Possibility From Smoking]
- CTRMN005105-5105 [Anti-Smoking Campaign Is Thought to Be A One-Sided Propaganda Effort]
- CTRMN005106-5106 [Questions Arise From on-Sided Study]
- CTRMN005107-5111 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Evidence on Smoking and Lung Cancer Is Accumulating, Among Other Contributing Factors]
- CTRMN005112-5117 [Comments Relating to Observation on Various Studies]
- CTRMN005118-5122 Research Grants Announced by Tobacco Industry Group [$500,000 Was Added to Research Funds, A List of Recipients with the New Grants Is Mentioned]
- CTRMN005123-5127 Research Supported by Tobacco Committee Discussed in Scientific Director's Report [It Seems That Finding An Answer to Lung Cancer and Cardiovascular Diseases Are Too Complicated]
- CTRMN005128-5128 [Attacks on Tobacco, the Lung Cancer Issue Is Still Not Settled]
- CTRMN005129-5129 Nta Stand on Smoking Repeats Opinions [Statement Gives No Evidence and Is Dealing Mainly with Opinions]
- CTRMN005130-5132 Tobacco Research Group Adds New Scientific Associate [New Scientific Director Was Added to the TIRC, Curriculum of J. Morrison Brady]
- CTRMN005133-5134 Tobacco Research Group Cites Questions Raised in Heart Statement [Lack of Evidence Proposes New Questions and Doubts About Cardiovascular Disease]
- CTRMN005135-5137 New Evidence Shows Complexities of Lung Cancer, Scientist Says [Hundreds of Studies Indicate Many Factors Contribute to the Complex Chain That May Result in Lung Cancer, No One Can Figure Out the Right Factor and Still the Reported Lung Cancer Cases Are Rising]
- CTRMN005138-5140 New Grants to Scientists Made by Tobacco Research Group [Research Grants Totalling $523,000 Made to 40 Scientists This Year]
- CTRMN005141-5144 Cancer Research Opens Up New Areas, Extra Funds Appropriated for Study [TIRC Stepping Up Financial Support of Independent Health Research]
- CTRMN005145-5147 Scientists in 11 States Get Research Grants for Tobacco-Health Studies [17 Research Grants Totaling Nearly $200,00 Awarded to Scientists in 11 States for Studies of Tobacco Use and Health]
- CTRMN005148-5151 New Direction for Tobacco-Health Research in '61, Says Chairman of Tobacco Industry Research Committee [Future Research to Concentrate on How Lung Cancer and Heart Disease Originate]
- CTRMN005152-5160 Research on Smoking and Health Discussed by Scientific Advisory Board to T.I.R.C. [Health Research Expansion Called for in 22 Specific Areas]
- CTRMN005161-5162 Scientist Reports on Research Progress As T.I.R.C. Boosts Funds to $4,650,000 [Dr. Clarence Cook Little Proposed Steps for Medical Research]
- CTRMN005163-5163 Nation's Medical Students Offered Research Fellowships by Tobacco Research Group [Program Designed to Encourage Research As A Career]
- CTRMN005164-5168 Scientists in 14 States Get Research Grants for Tobacco-Health Studies [Fifteen Grants for New Research Announced]
- CTRMN005169-5173 Tobacco Industry Research Committee Adds $800,000 for New Research [Emphasis Put on Viruses, Bioassay, Psychological and Physiological Research]
- CTRMN005174-5176 ""Significant Developments" in Cancer Research Reviewed in Annual Report by Dr. C.C. Little" [Scientific Findings of the Past Year Reviewed]
- CTRMN005177-5179 Tobacco Research Group Offers Fellowships to Medical Students to Spur Interest in Research Work [Program Designed to Encourage Career in Research]
- CTRMN005180-5180 Tobacco Research Committee Chairman Comments on Mouse Skin Painting [Harmless Everyday Substances Can Cause Cancer in Laboratory Animals]
- CTRMN005181-5182 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005183-5217 Smoking-Health Situation Calls for Facts, Not Emotions, Says Hartnett [Repetition Does Not Add to Scientific Knowledge]
- CTRMN005218-5224 52 Additional Research Grants Made by Tobacco Industry Group [Money for Studies Designed to Give New Leads to Lung Cancer and Other Health Problems]
- CTRMN005225-5225 Medical Student Fellowships Offered by Tobacco Research Group [Program to Encourage Research]
- CTRMN005226-5228 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [Multiple Factors and Influences That Contribute to Lung Cancer Unknown]
- CTRMN005229-5230 Scientific Director of Tobacco Industry Research Committee Comment on Resolution by American Heart Association [TIRC Welcomes Recognition of Need for Further Research to Determine Full Facts About Smoking]
- CTRMN005231-5234 Tobacco Committee Adds $1 Million for Continuing Research Studies [Scientific Advisory Board Assured TIRC Will Provide More Funds]
- CTRMN005235-5235 [Scientific Director of TIRC Sent Telegrams to the Surgeon General and the President of the Ama]
- CTRMN005236-5236 [Ama Supports Research on Tobacco and Health]
- CTRMN005237-5239 [TIRC Renamed and Reorganized]
- CTRMN005240-5241 Dr. Howard B. Andervont Named to the Scientific Advisory Board [Editor of the Journal of the National Cancer Institute Appointed]
- CTRMN005242-5277 Tobacco Industry Group Awards $817,165 for Health Research [37 Additional Research Grants Have Been Awarded by the Ctr]
- CTRMN005278-5282 Scientific Director C.C. Little Reports Decade of Tobacco-Health Research [Findings on What Diseases Smoking Can Cause]
- CTRMN005283-5286 Council Awards $500,000 for Tobacco and Health Research [Number of Grants Awarded for Tobacco Use and Health Research]
- CTRMN005287-5291 Summary of the Testimony of Clarence C. Little Before the Senate Commerce Committee [Discussion on Cancer and How It Affects Our Bodies]
- CTRMN005292-5319 Council Awards $514,767 for Tobacco and Health Research [Number of Grants Awarded to Scientist Over the Period of 10 Years]
- CTRMN005320-5348 Tobacco - Health Studies Reviewed in Annual Report [Discussion on Cigarette Smoking Being Helpful with Causing Diseases in Smokers]
- CTRMN005349-5367 Tobacco and Health Research Awards Pass $9 Million Total [Grants Given to Scientist Studying Matter Related to Tobacco Use and Health]
- CTRMN005368-5375 Tobacco-Health Research Grants Awarded New York Scientists [Scientists Approved to Continue Research on Lung Cancer and Other Diseases]
- CTRMN005376-5382 Tobacco - Health Studies Reviewed in Annual Report [Studies of the Respiratory System in Experimental Animals and Human Patients Especially on Causes of Pulmonary Cancers]
- CTRMN005383-5384 [Opinions of Scientists That There Is No Relationship Between Smoking and Disease]
- CTRMN005385-5387 New Tobacco-Health Research Grants Total $2 Million [Number of Approved Grants for Studies on Tobacco Use and Health]
- CTRMN005388-5388 Furst Becomes Consultant to Tobacco Research Council [Dr. Furst Advise to Council on Programs Sponsored by Them]
- CTRMN005389-5393 Studies Raise Questions About Smoking As Health Hazard [Numerous Studies Done to Show What Effect Smoking Had on Our Health]
- CTRMN005394-5400 Broad Review of Tobacco-Health Picture Covered in Dr. Little's Latest Report Lung Cancer, Heart Disease, Chronic Pulmonary Ailments Are Complex in Nature, Says Noted Researcher Genetic and Environmental Factors May Be Involved Reports Scientific Director of Council for Tobacco Research [Recent Research Finding on Lung Cancer, Heart Disease and Chronic Pulmonary Ailments]
- CTRMN005401-5404 Significant Smoking-Health Finding Covered in Report by Dr. C.C. Little [Findings From Independent Scientists on Smoking and Health]
- CTRMN005405-5408 New Tobacco-Health Grants Announced; One Helps Revive Framinghan Heart Study [Awards Granted to Independent Scientists Researching Tobacco and Health]
- CTRMN005409-5412 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research [New Findings From Independent Scientists Relating to Tobacco and Health Issue]
- CTRMN005413-5415 New Smoking-Health Studies Boost Total to $23-Million [Council Awards More Grants to the Study of Lung Cancer, Viruses and Cancer, Heart Disease, and Chronic Pulmonary Ailments]
- CTRMN005416-5418 Progress in Tobacco-Health Research Achieved: Machines That Simulate Human Smoking [Machines to Help Scientists Effectively Study Smoke and Health Issues]
- CTRMN005419-5421 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research [Dr. Hockett Who Was Acting Scientific Director Got Promoted to Research Director]
- CTRMN005422-5425 Massive Cancer Study Using Made-to-Order Mice [Study Using Mice to See If Human Lung Cancer Can Be Induced Regularly]
- CTRMN005426-5427 Tobacco Research Group Announces New Studies [12 New Studies Have Been Funded to Study Generic Factors in Lung Cancer and Emphysema and the Possible Influence of Nicotine on Fetal Growth]
- CTRMN005428-5429 Studies of Twins Expanded by Tobacco Research Group [Human Twins Used for Study to Determine Effects of Environment Agents on Various Diseases]
- CTRMN005430-5432 News About Smoking and Health Study Interaction of Genetic and External Influences in Lung Cancer [Studies Show That Only Minority of Smokers Get Lung Cancer Therefore Lung Cancer May Be Caused by Genetic Characteristics or External Influences Which People Have Been Exposed]
- CTRMN005433-5434 New Smoking and Health Grants Made by Tobacco Research Council [New Studies Have Received Grants to Continue Researching on Smoking and Health]
- CTRMN005435-5435 Yeaman Assumes Leadership of Council for Tobacco Research [Addison Yeaman Succeeds H.H. Ramm for Chairman and President of the Council for Tobacco Research]
- CTRMN005436-5438 14 New Studies Funded by Tobacco Research Council [Grants Awarded to Studies for Inhibition of Cancer by Different Chemicals, the Influence of Nicotine on Pregnancy and the Effects of Cigarette Smoke on the Body's Disease Fighting System]
- CTRMN005439-5441 Progress Being Made in Research on Emphysema [Scientist Discover Ways to Help Defend Against Emphysema]
- CTRMN005442-5444 14 New Smoking-Health Projects Are Approved [Recent Research Studies Dealing with Smoking and Health Have Been Given Grants]
- CTRMN005445-5446 Grants Awarded for New Smiking-Health Studies [Scientists Were Approved for Studying of Certain Enzymes in Human Lung Cancer and Emphysema]
- CTRMN005447-5448 Tobacco Research Report Discusses Heart Disease [Studies Have Found Progressive Atherosclerosis Rank First As Number One As Causes of Death From Cardiovascular Disease]
- CTRMN005449-5451 Grants Awarded for New Smoking-Health Research [New Studies Have Been Approved for Marker Substance That May Indicate Presence of Lung Cancer and on Smoking and Pregnancy]
- CTRMN005452-5453 Tobacco Research Group Funds New Smoking-Health Projects [A New Study for Relationship of Childhood Respiratory Disease to the Development of Adult Chronic Lung Disease]
- CTRMN005454-5455 Tobacco Research Group Reports... Funds for Smoking-Health Studies Pass $46,000,000 [Amount Council Has Given to Scientist for Research]
- CTRMN005456-5458 $5.9 Millions Given for Smoking-Healths Studies [Council Has Given Millions Over the Years to Researchers]
- CTRMN005459-5460 Tobacco Research Group Says... Continued Research Needed to Find Causes of Cancer and Other Major Diseases [Council Pledges to Continue to Give Financial Support to Scientists Studying Smoke-Health Issues]
- CTRMN005461-5462 $6 Million Granted for Smoking-Health Studies [Millions Given to Scientist for Further Study]
- CTRMN005463-5465 Tobacco Research Group Continues Funding for Independent Scientists [Council Has Provided Millions Over the Years to Researchers and Will Continue to Do So]
- CTRMN005466-5467 $5.5 Million Given for Smokin-Health Studies [Council Has Given Millions to New and on Going Studies Over the Years]
- CTRMN005468-5469 Annual Report Issued by Tobacco Research Group [Over 1.5882 Reports From Scientists Acknowledging Support From the Council Have Been Published]
- CTRMN005470-5473 $6 Million Awarded for 34 New Smoking-Health Studies [Millions Were Given to Scientists with New Studies and Continuing Ones From the Council]
- CTRMN005474-5474 Ctr's Latest Report Sets Abstract Record [More Reports Were Published From Scientists Acknowledgingg Support From Council for Tobacco Research Than Any Other Report Published in the Past]
- CTRMN005475-5475 Scientists Show... Growing Interest in Doing Smoking and Health Studies [Growing Number of Application Have Gone to the Council of Tobacco Research for Funding on Smoke Related Diseases]
- CTRMN005476-5479 $7 and A Half -Million Awarded for Smoking-Health Research [Millions Given to Scientists for Studying Lung Disease]
- CTRMN005480-5481 Council for Tobacco Research Announces... Hoyt and Hockett Retire After 30 Years: Gertenbach Is Named New President [Introduction to President of the Council for Tobacco Research]
- CTRMN005482-5482 Ctr's Annual Report Sets Abstract Record [the Number of Reports Acknowledging Support by the Council of Tobacco Research Is More Today Than It Was Years Ago]
- CTRMN005483-5485 Findings Published on Cigarette Smoke Inhalation Study with Mice [Results From Study Show That Smoke Did Not Produce Any Squamous Cell Lung Cancer]
- CTRMN005486-5525 Statement of Dr. Clarence Cook Little, Scientific Director, Tobacco Industry Research Committee, at Press Conference, University Club, New York City, June 15, 1954 [Regarding Relationship Between Lung Cancer and Tobacco]
- CTRMN005526-5533 "Transcript of Edward R. Murrow's First Tv Show on "Cigarettes and Lung Cancer"" [Regarding Experiments That Show That Cigarette Smoking Increases Chances for Lung Cancer]
- CTRMN005534-5541 "Transcript of Edward R. Murrow's Second Tv Show on "Cigarettes and Lung Cancer"" [Regarding Issue That Cigarette Smoke Does Not Cause Lung Cancer]
- CTRMN005542-5562 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Regarding Continuation of Study Dealing with Tobacco and Health]
- CTRMN005563-5573 A Report of Progress [Results From the Study of Smoking and Health Issue Will Greatly Depend on Well Planned and Well-Executed Scientific Research]
- CTRMN005574-5585 Tobacco and the Cardiovascular System the Program of the Tobacco Industry Research Committee [Program Strives to Discover Facts and Relationships Described with Objectivity]
- CTRMN005586-5597 A Search for Facts [Regarding Information Needed to Be Gathered on Smoking and Health Problems to Defend Industry]
- CTRMN005598-5605 the Lung Cancer Problem and the Research Program of the Tobacco Industry Research Committee [Discussion on Different Studies Will Continue to Be Made Until A Answer Is Found]
- CTRMN005606-5607 Cancer Research Guest Editorial Smoking and Lung Cancer Volume 16 [St Regarding Support Given to Scientist for Research]
- CTRMN005608A-5609 "Correspondence Regarding "Smoking and Health"" [Discussion on Researching on Tobacco and Health with Objectivity and Not Be Judgmental]
- CTRMN005608B-5609 Hypfibrinogenemia [Regarding Transfusions and Clotting Mechanism in A Case of Extraordinarily Delayed Post-Partum Hemorrhage]
- CTRMN005608C-5609 Diabetic Children [Admitting Omission of Different Data From Other Sources]
- CTRMN005608D-5609 Revocation of Licenses [Revoking of Registration From Dr. Louis A. Scinta]
- CTRMN005610A-5613 Mayo Clinic Head Believes Smoking Not Cancer Cause Tobacco and Health Volume 1 Number 1 [Smoking Not Believed to Be Cause of Lung Cancer, According to Some Noted Physicians]
- CTRMN005610B-5613 Six Experts State Doubts on Smoking-Cancer Theory Tell Congressmen Reasons for Position Tobacco and Health Volume 1 Number 1 [Reasons for Not Accepting Theory That Smoking Causes Lung Cancer]
- CTRMN005610C-5613 New Book Says Tobacco 'scare' Not Justified Tobacco and Health Volume 1 Number 1 [""Science Looks at Smoking"]
- CTRMN005610D-5613 Editors View Smoking-Cancer Tie As Unproved, Open Question Excerpts From Editorials Tobacco and Health Volume 1 Number 1 [Excessive Smoking Probably the Main Cause of Lung Cancer, While Moderate Smoking As Causation of Lung Cancer Has No Scientific Support]
- CTRMN005610E-5613 British Scientist Opposes Campaign Against Smoking Tobacco and Health Volume 1 Number 1 [Sir Ronald Fisher, British Statistician, Refuses to Produce Anti-Smoking Writing, States It As A Cause for Anxiety]
- CTRMN005610F-5613 'pick Your Expert, Take Your Choice' Tobacco and Health Volume 1 Number 1 [Witnesses Linking Cigarettes to Lung Cancer Testify Before House Operations Sub-Committee]
- CTRMN005610G-5613 'still Open Question' Tobacco and Health Volume 1 Number 1 [Authorities on Cancer State That Smoking Is Not Proven to Cause Lung Cancer]
- CTRMN005610H-5613 Smoking and Death Rates Tobacco and Health Volume 1 Number 1 [If Everyone Stopped Smoking There Would Be No Significant Change in Death Rate]
- CTRMN005614-5616 Summary of Comments for Delivery Before: Central Subsection, North Jersey Section, American Chemical Society, Elizabeth, New Jersey [Review of the Chemical Analysis of Cigarette Smoke and Investigations of Smoking and Lung Cancer]
- CTRMN005617-5620 the Public and Smoking Fear or Calm Deliberation? [How Doubt, Suspicion and Fear May Affect the Deliberation of Whether Cigarette Smoking Causes Lung Cancer or Other Ailments]
- CTRMN005621A-5624 TIRC Reports Progress in Smoking-Health Research Tobacco and Health Volume 1 Number 2 [Too Many Unknowns Exist Concerning Lung Cancer to Warrant Conclusions Citing Smoking As Causation of Lung Cancer]
- CTRMN005621B-5624 'tar' Misnomer for Condensed Smoke Tobacco and Health Volume 1 Number 2 [Difficulties in Analyzing Tobacco Smoke Make Tobacco Tar A Misnomer]
- CTRMN005621C-5624 New Statistics Contradict Anticigarette Theory Tobacco and Health Volume 1 Number 2 [Cigarette Smoking May Be Compatible with Normal Health Report on Done Smokers Who Have Longer That Average Life Span]
- CTRMN005621D-5624 TIRC Funds for Smoking Research Now Over $2,000,000 Tobacco and Health Volume 1 Number 2 [Scientific Advisory Board Approves 52 Grants and Renewals in 1957 Totalling $550,000]
- CTRMN005621E-5624 Press Questions Anti-Smoking Plan Tobacco and Health Volume 1 Number 2 [State-Supported Campaign Against Cigarettes Warranted in New York]
- CTRMN005621F-5624 Study Suggests Bronchitis May Be Prime Factor in Lung Cancer Tobacco and Health Volume 1 Number 2 [Preliminary Study at Beatty Institute Favors Bronchitis As A Factor of Lung Cancer]
- CTRMN005621G-5624 Doctors' Comments on Smoking-Health Tobacco and Health Volume 1 Number 2 [Increasing Number of New Chemicals in the Atmosphere at Fault for Rise in Cancer]
- CTRMN005621H-5624 Nation-Wide Lung Tissue Study Now Being Evaluated Tobacco and Health Volume 1 Number 2 [TIRC Studying Lung Tissues From 1,600 Persons]
- CTRMN005625-5648 Biological Aspects of Cancer Research Journal of the National Cancer Institute Vol. 30, No. 3 [St Background Research and New Information on Cancer Studies]
- CTRMN005649-5654 Interview the Cigaret Smoker and Lung Cancer Reprinted From Modern Medicine, Vol 26 [St Advises on Smoking and Its Relation to Health]
- CTRMN005655-5660 Comments on the Mortality of Smokers and Non-Smokers. A Paper by Harold W. Dorn Before the American Statistical Association Dec. 27, 1958 [Reflections on Figures Presented in Dorn's Paper]
- CTRMN005661-5671 An Experimentalist Looks at Statistics on Smoking [Reflections on the Figures in Dorn's Paper]
- CTRMN005672-5672 Letters to the Times Findings on Smoking [Statistical Proof of Link Between Smoking and Cancer Denied]
- CTRMN005673-5683 A Brief Review of the Smoking-Lung Cancer Theory [Review of Data Known on the Relation Between Cigarette Smoking and Lung Cancer]
- CTRMN005684-5686 Cancer-the Research Approach [Discussion on Cancer and A Category of Factors Which May Play Roles in Cause and Development of Cancer]
- CTRMN005687-5692 [Address Before the Burley and Dark Leaf Tobacco Export Association, Inc. Information About the Research Program Supported by the TIRC]
- CTRMN005693-5697 Some Phases of the Problem of Smoking and Lung Cancer the New England Journal of Medicine Vol. 264 No. 24 [St Disputes Findings That Smoking Causes Lung Cancer]
- CTRMN005698-5704 Some Aspects of the Lung Cancer Problem Reprinted From Punjab Medical Journal Vol. Xi No. 7 [St Discussion of Relationship of Cigarette Smoking to Lung Cancer]
- CTRMN005705-5735 Current Knowledge of Tobacco and Health [Discussion of Experimental Attack on Lung Cancer and Tobacco Use]
- CTRMN005736-5739 Cigarettes-Why More Research? Reprinted From the Yale Scientific Magazine [St Comments on the Uncertainties of the Correlations Between Cigarette Smoking and Lung Cancer]
- CTRMN005740-5740 Why Do People Think That Quitting Smoking Affects Their Appetite or Their Weight? the Apothecary [St Comments on the Scientific Basis of How Smoking Affects Hunger]
- CTRMN005741-5754 Address to Be Delivered by Dr. Clarence Cook Little, Scientific Director, the Council for Tobacco Research - U.S.A. At A Dinner Honoring the Centennial of the University of Kentucky and the Burley Tobacco Industry Lexington, Kentucky January 12, 1965 [Talk Addressing Research Programs of the University of Kentucky]
- CTRMN005755-5772 Communications and the Biological Sciences [Brief Discussion of Principles That Should Inspire and Guide Communications in the Biological Sciences]
- CTRMN005773-5785 Perspectives in the Experimental Approach to the Human Lung Cancer Problem [Experimental Research on Lung Tumors in Animals May Lead to Insights on Human Lung Cancer]
- CTRMN005786-5798 Tobacco and Health Research [Elaboration on the Purpose, Research Practices and Studies of the TIRC]
- CTRMN005799-5805 Tobacco and Health Research [Discussion of Experimental Studies by the TIRC Concerning Smoking and Health]
- CTRMN005806-5813 the Research Perspective on Smoking and Health [Discussion on the Search for Causes of Diseases with Which Smoking Has Been Associated]
- CTRMN005814-5820 Tobacco and Health Research [Discussion of Studies on Cigarettes and the Diseases Statistically Associated with Smoking]
- CTRMN005821-5834 Tobacco and Health Research - Where Shall We Go From Here? [Suggestions for Continuing Studies and Research on Cigarette Smoking and Health]
- CTRMN005835-5852 A Look Ahead Smoking and Health - Where Do We Stand? [Talk on Chronic Diseases and Factors of Their Causation and Development in Relation to Cigarette Smoking]
- CTRMN005853-5854 Smoking-Disease Links Continue to Lack Scientific Proof [Discusses the Role of the Council for Tobacco Research]
- CTRMN005854-5854 Lawrence Promoted to Vp Post at Mmi [Jack Riddle Announces the New Vp of Micro-Magnetic Industries]
- CTRMN005854A-5854 Philip Morris Expands Promotional Allowances [Discusses Special Offers Made to Philip Morris Vendors]
- CTRMN005855-5882 Chapter 3 the Tobacco Health Issue: An Overview of Medical Research [St Questions Methodology of Experiments Where the Sole Objective Was the Attempt to Induce Tumors]
- CTRMN005883-5900 the Research Program (Cancer Segment) of the Council for Tobacco Research - U.S.A., Inc. Presentation Before the Tobacco Working Group [Describes the Concept, Plan, and Purpose of the Council for Tobacco Research]
- CTRMN005901-5902 Smoking Prevention Education Act Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 [Statement of Sheldon C. Sommers]
- CTRMN005903-5919 [Regarding Anti-Smoking Bill]
- CTRMN005920-5931 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Eighth Congress First Session on H.R. 1824 March 9 and 17, 1983 Serial No. 98-8 Statement of Robert Casad Hockett Regarding H.R. 1824 [Disputes Findings Set Forth in H.R. 1824 Regarding Cancer, Cardiovascular Disease, Atherosclerosis and Emphysema]
- CTRMN005932-5932 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 May 5 and 12, 1983 [Concerning Smoking Prevention Health and Education Act of 1983]
- CTRMN005933-5940 Statement of Sheldon C. Sommers, M.D., Consultant in Pathology, Lenox Hill Hospital, New York, N.Y. [Comments on Smoking Prevention Health and Education Act]
- CTRMN005941-5963 Hearings Before the Committee on Labor and Human Resources United States Senate Ninety-Eighth Congress First Session on S. 772 to Promote Public Health by Improving Public Awareness of the Health Consequences of Smoking and to Increase the Effectiveness of Federal Health Officials in Investigating and Communicating to the Public Necessary Health Information, and for Other Purposes Statement of Robert Casad Hockett Regarding S. 772 [Disputes Methodology of Experiments Which Expose Animals to Smoke]
- CTRMN005964-6009 Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives Ninety-Seventh Congress Second Session on H.R. 5653 and H.R. 4957 March 5, 11, and 12, 1982 Serial No. 97-106 [Disputes Methodology of Experiments to Demonstrate That Cigarette Smoking Can Cause Lung Cancer in Animals]
- CTRMN006010-6012 Testimony of Dr. Robert C. Hockett During Hearing on Cigarette Smoking and Health Before the Subcommittee on Oversight and Investigations of the House Committee on Interstate and Foreign Commerce, October 5, 1978 [Responds to Question Regarding Research on Health and Smoking]
- CTRMN006013-6023 Statement of Robert C. Hockett, Ph.D. Before the Subcommittee on Oversight and Investigation of the Committee on Interstate and Foreign Commerce in Response to the Letter Dated September 27, 1978 From the Chairman of the Subcommittee to William U. Gardner, Ph.D., Scientific Director, the Council for Tobacco Research - U.S.A., Inc [Discusses the Purpose of the Council for Tobacco Research]
- CTRMN006024-6069 Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare United States Senate Ninety-Fourth Congress Second Session on S. 2902 February 19, March 24, and May 27, 1976 [Disputes Scientific Basis of S. 2902]
- CTRMN006070-6125 Hearings Before the Consumer Subcommittee of the Committee on Commerce United State Senate Ninety-Second Congress Second Session on S. 1454 Serial No. 92-82 [Discussion of Cigarette-Smoking and Peptic Ulcers]
- CTRMN006126-6135 Report of the Scientific Director [St]
- CTRMN006136-6189 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 February 1, 5, and 10, 1972 [Discusses Edimeological Comparisons Between Smokers and Non-Smokers]
- CTRMN006190-6200 [Bibliography Listing Over 1,275 Articles and Books About Tobacco and Disease]
- CTRMN006201-6311 [Articles About Tobacco and Disease]
- CTRMN006312-6321 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Sheldon C. Sommers]
- CTRMN006322-6348 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statement of Dr. Robert Casad Hockett]
- CTRMN006349-6359 Hearings Before the Consumer Committee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [Statements of Dr. Sheldon C. Sommers and Dr. Robert C. Hockett]
- CTRMN006360-6370 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes [References Reporting on Tobacco and Nicotine]
- CTRMN006371-6412 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Ninety-First Congress First Session on H.R. 643 A Bill to Amend the Federal Cigarette Labeling and Advertising Act with Respect to the Labeling of Packages of Cigarettes and for Other Purposes (and Similar Bills) [Statement of Dr. Sheldon C. Sommers]
- CTRMN006413-6492 Hearings Before the Committee on Commerce United States Senate Eighty-Ninth Congress First Session on S. 559 and S. 547 Bills to Regulate Labeling of Cigarettes and for Other Purposes [Statement of Dr. Clarence C. Little]
- CTRMN006493-6533 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So to Make That Act Applicable to Smoking Products [Statement of the Council for Tobacco Research U.S.A. History and Organization]
- CTRMN006534-6540 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Clarence Cook Little, SC.D.]
- CTRMN006541-6548 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Eighty-Ninth Congress First Session on H.R. 2248 A Bill to Amend the Federal Food, Drug, and Cosmetic Act So As to Make That Act Applicable to Smoking Products [Statement of Robert Casad Hockett, Ph.D.]
- CTRMN006549-6577 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement of Dr. Clarence Cook Little]
- CTRMN006578-6611 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Statement Concerning the Origin and Purpose of the Tobacco Industry Research Committee and Its Proposed Functions]
- CTRMN006612-6614 False and Misleading Advertising (Filter-Tip Cigarettes) Hearings Before A Subcommittee of the Committee on Government Operations House of Representatives Eighty-Fifth Congress First Session [Hartnett Cites Scientists Doubting Smoking-Cancer Theory]
- CTRMN006615-6618 Research Into Smoking and Health [Arguments Against Tobacco Cancer Link]
- CTRMN006619-6623 [Study to Examine Reported Causes of Death in Each of 17 Regions in Houston Specifically the Five Major Respiratory Diseases]
- CTRMN006624-6624 A Frank Statement to Cigarette Smokers [Industry Promotes Research Into Tobacco Disease Link]
- CTRMN006625-6625 the Council for Tobacco Research - U.S.A., Inc. Board of Directors [Members of the Board]
- CTRMN006626-6627 the Council for Tobacco Research - U.S.A., Inc. Scientific Advisory Board [Members of the Board]
- CTRMN006628-6634 No. E-121,486 I. D. Rogers, Individually and As Independent Executor of the Estate of Marjorie Helen Rogers, Deceased; Et Al Vs. R. J. Reynolds Tobacco Company, Et Al in the District Court of Jefferson County, Texas 172nd Judicial District Third Amended Notice of Intention to Take Oral Deposition [Matters on Which Ctr Witnesses Must Be Knowledgeable]
- CTRMN006635-6967 Deposition of Dr. James Glenn [Deposition of Glenn in the Matter of Broin]
- Author
- Little, C.C.
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 002
- UCSF Legacy ID
- bnq30a00
Document Images
ANNUAL REPORT
of trre
SCIT;ITIPIC I)IItECTOTi
Ci;Attl;nCT; COOK LITTLE, Sc:1>.

SCIENTIFIC ADVISORY ItOARD
to The Council for Tobacco Research - U.S.A.
KENNETH MERRILL LYNCH, M.D., Sc.D., LL.D., Chairman
Chancellor and Professor Emeritus of Pathology
Medical College of South Carolina, Charleston, South Carolina
HOWARD B. ANDERVONT, Sc.D.
Scientific Ediror, The Journal of the National Cancer Institute
Bethesda, Maryland
RICHARD M. BING, M.D.
Director of Cardiology and Intrnmarnf MtdJdnt
Huntington Memorial Hospital, Pasadena, Califotnia
Professor of Medicine
University of Southern California School of Medicine
Los Angeles, CaGfornia
McKEEN CATTELL, PttD., M.D.
Prof essor Emeritus of Pharnacoiov
Cornell University Medical College, New Yodr, New York
ROBERT J. HUEBNER, M.D.
Chief, Viral Carcinogeneaia Branch
National Cancer Institute
Bethesda, Maryland
LEON O. JACOBSON, M.D.
Dean of the Divislon of Bioloafcn! Scltncw
Regenstein Professor of Bioloslca! Sdencts
University of Chicago, Illinois
CLAYTON G. LOOSLI, Px.D., M.D.
Nasrinas Professor of Medicine and Pathotoay
University of Southern California School of Medicine
Los Angeles, California
CLARENCE COOK LITTLB, Sc.D., LLD., Lrrr.D.
Scientific Dirccto., The Council for Tobacoo Research - U.S.A.
Director Emerltrrs, Rosooe B. Jacbon Memorial Laboratory
Bar Harbor, Maine
WILLIAM F. RIENHOFF. Jr;., M.D.
Prof tssor Enxrttut of SwYery
Johns Hopkins University School of Medclne, BaltSmore, Maqiasd
SHELDON C. SOMMERS, M.D.
Research Director. The Council for Tobweo Reiewh - US.A.
Director of Laboratories, Lenox Hill Hospital
Professor of Pathology
Columbia University College of Physiciam and Surgeons
New York, New York '
ROBERT C. HOCKETT, Pn.D.
Associate Scientific Director
J. MORRISON BRADY, M.D. JOHN H. KREISHER, P1t.D.
Associate Scientific Director Atsiocrore Scientific Director
VINCENT F. LISANTI, D.M.D.
Scientific Associate
RNf.rd

CoN'PF.IVTS
Introduction . . . . . . . . . . . . . . . . . . . 5
Status of Current Research . . . . . . . . . . . . . . 6
Multivariate Analysis . . . . . . . . . . . 6
Cancer . . . . . . . . . . . . . . . . . . 8
~
Cardiovascular Diseases . . . . 12
Nicotine: Psycho-Pharmacologicil and Behivioral Effects . . 14
Chronic Respiratory Diseases . . . . . . . . . . . 15
Abstracts of Reports . . . . . . . . . . . . . . . . 18
Psyr.ho-Physiolobical Studies . . . . . . . . . . . 18
CarciooSenesis Studies . . . . . . . . . . . . 22
Cardjv.a_.wlar System . . . . . . . . . . . . . 3 2
Respiratory System . . . . . . . . . . . . . . 45
Neurophysiology . . . . . . . . . . . . . . . 55
Studies at the Cellular L.erel . . . . . . . . . . . 58
Cd1 and Tissue Cuiture . . . . . . . . . . . . . 62
EP4demWoaJ' . . . . . . . . . . . . . . . . 67
Pharmacology and Psycho-Pharmaooio8y . . . . . . . 69
Metaboi"ic Studies . . . . . . . . . . . . . . 77
Cxrnistrr and Biochemistry . . . . . . . . . . . 81
Other Studiea . . . . . . . . . . . . . . . . 84
Re.iews . . . . . . . . . . . . . . . . . 86
Recipients of Active Pro;ects . . . . . . . . . . . . . 94
Reeipicnts of Compkted Projects . . . . . . . . . . . 106
Introduction
The Council for Tobacco Researd+-US.AA aas established in 1954
for the purpose of providing 5nancial support for ttsnrch by independent
scientists into all phases of tobacco use and heahb.
From the beg3nning, full authority and responsibility for policy, de-
velopment and direction of the raeatth effort were Stan to a Scientific
Advisory Board to The Council. T1us Board eanzently consists of 10
physicians and scientists who tet.ain their afNiatioos with their respectire
institutions.
With their oombined experience and knowledae, and with the advice of
other experts from the scientific community, the members of the Advisory
Board have worked toward one aoal--to develop a research program to
provide significant data about lung cancer, heart disease, chronic respiratory
ailments, and other diseases.
Through the years The ConncH has pro.ided the funding to enable the
Scientific Advisory Board to develop and expand the raarth program.
From 1954 through June 1969, the Board awarded over 400 original
gants, and many more renewals, to 239 rc3enthts in 196 hospitals, medical
schools and research institutSona. In the sante petiod, these research workers
published 728 scientific papers on their stndies, supported in whole or in
part by The Councit, in the profesaional literatute.
Studies from the Advisory Board's program and from other proEran»
have produced much valuable data In the paat 13 yeat:.
They show, however, that we are not dealing with simple diseases and
that we cannot expect simple answers. But the toeatbt~ of the Board and
of other scientific organizatkns are optimistic tbat aaswes will be found.
Investigators are constantly reporting resulta that will some day be pieced
together to help solve the pnalo of these tomplex dbeases.
It is apparent from the great amount of reaea:eb teported so far ttut
a variety of genetic and environmental taet+xu may be invoired. The
Council for Tobacco Research will continue to suppott scientific imestip-
t;on and to work toward a better undtxstandFaa of the many unanswered
questions that remain.
The response from physiciana and scientists in leadins institutioes to
The Council's oRer of research support is nwst gratifying and enoouraaea
The Council to adhere to the demands of a realistic and ackntille appraoach..
5

r
.
Status of Current Research
Certain epidemiological studies have associated cigarette smoking with
total mortality and morbidity rates and with mortality from lung cancer,
cardiovascular diseases, chronic pulmonary ailments, and various other
diseases. These associatiott: have been widely interpreted as signifying a
causal role for smoking. However, it is an accepted fact that a statistical
assodation is not necessarily one of causation. The information obtained
from epidemiological studies may be helpful to investigators in framing
necessary experimental studies.
Underlying most present interpretations of these epidemiological
studies is an assumption that cigarette smokers and nonsmokers are
sufficiently similar in other respeets so that it is legitimate to compare
their morbidity and mortality experience and to attribute observed differ-
ences to a sole factor, Ymoking.
The restricted monofactorial interpretation of smoking as a causal
factor in total mortality or in relation to certain diseases ignores the validity
of a vast amonnt of reaearch relating to the possible influence of many
other factors or combination of factors.
Multivariate Analysis
~ Three questions abotrt epidemidogial studks reported on tobacco
~ are: (1) Is cigarette smoking really a cause of incteased mortality, either
-~ in general or from certain diseases? (2) How and to what extent do
® smokers and nonsmokers differ in genetie traits or genetically-inftuenced
habits and patterns of IiviaS7 (3) Are these genetic traits or genctically-
irdlnenced habits and paftrts of living themselves, singly or in groups.
Influential with regard to death ateaT
Stathticiana generally agree that it is Important to weight all known or
possible factors, individually and In groups, as mathematical predictors of.
any event (sach as mortality) preliminary to selecting those worthy of
tArelative priority. This is a very laborious task because numerous factors are
00 ~
00
6
involved, and most of the large data collections that might bear on the
predictors for longer or shorter life have not been so analyzed.
Any meaningful analysis, of course, requires that adequate and
accurate data on such factors have been gathered inithlly. Of equal im-
portance is the need for developing new, reliable and faster eompttter
methods capable of handling these complex data.
Aware of this problem, The Council for Tobacco Research is engaged
in the study of the development of such methods.
Pilot Study of Longevity
A pilot study of longevity has been done in a group of S00 recently
deceased veterans in the Boston ares. A large body of information has been
collected on these subjects as part of a Cotmcil-tupported project. The ne+w
methods of multivariate analysis were applled to see which factors would
have served as the best predictors of longer or shorter life, if they had
been so employed at the outset. Many factors, it was found, tended to
"cluster" with cigarette smoking statistically so that good predictioen of
longevity (in these data) could be made by t»e of a"proHk" of such
other factors with smoking itself oeritted as a predictor. The resnlt was
substantially the same as when smoking alone was used. In other words,
the finding showed that smoking (and afso alcohol tm) appeared to
"summarize" and.to be associated with other groups of charaderistkY.
There was a significant by-prodnct of this new approach. it..as found
that certain statistical asssociations between cigarette smoking and length of
life can be explained by the secularity effeet-that is, the general change
in prevalence and level of cigarette smoking with time. Secularity is de-
scritxd in the words of the in.estigaton: a consequence of rapid social
change and the prolonged human life span. Thtts, the younger decedents
were part of a "selected" population hating, perhaps inddentally, a different
cigarette smoking pattern than did the population tepresented by the older
decedents.
It is expected that these prelimit>:q applications of tmthivariate .
analysis will be carried out on data ootlected In several other Conncil-
sponsotrd projects on subjects not necessarily related to longevity but to
methods of diagnosis, etc.
Differences Between Smokers end Nonsmokers
Other Council-sopported projects have shown statistically aignifiant
differences between smokers and ttonsmoken. These are indications for pos-
sible use in the multivariate te-analysis of existing data collections. It has
7

been shown, for example, that there is a prevailing difference in the dis-
tn'bu6oo of body build types. Investigators have found personality diRer-
ences. One researcher has reported observations on a number of factors
that differ la smokers and nonsmokers and may be predictors of early
heart and artery diseaae. Still another researcher has found a significant
dGlfererxr in basic brain wave patteras of smokers and oonsmoken.
Cancer
Lwrg Cancer
Sneoke Iwhel.tion Espertraents
Previous Anmr.t Reports have specified the exacting criteria for con-
ducting realistic experiments involving smoke inhalation. It is important
to restate these criteria which have beee derived from the results of exten-
sive research and from consultations with experts in many disciplines.
First and forernoat, meaningful data can be obtained only if the
whole smoke delivered to the various parts of the respiratoty tract of the
animal is In the saase physical and chemial state as that which reaches
similar anatomical areas of the human during normal cigarette smoking.
To accomplish this, it is necessary to have a mechanical device-a
amoking awchine-4hat simulates human smoking as closely as possible.
711s device should be able to deliver pulsed amounts of smoke in a quan-
titative and reproducible manner. The machine should be so designed and
coostruct+ed diat it will be possible to measure accurately the time between
two soooessFve puffs, the time of the puff, the volume of the puff, the
e=tent of dilution with air, and the number of puffs per cigarette. Care
mant be taken so that the temperature of the burning tip does not exceed
-hat reached when a haman smokea a cigarette, nor should the cigarette be
,~ll smoked" beyond a minimqm butt length.
~ 'Il+e macfiise sbocld have a port to permit sampling of the smoke
a stream for chemical or gtu chromatographic analysis, if desired. For frac-
® tionating the whole smoke and to permit the bio.:say of the gaseous phase,
the smoking machints should be designed so that a Cambridge filter can be
attached. For comparison between laboratories, It Is desirable that a refer-
ence type cigarette be used. (The University of Kentucky is now producing
a referenoe efguttte.)
The animai r+eoetvthe aeiote should be placed so that only its
breathina apparatus i. In the t~tream of the smoke and no farther than
~+.
E
00
~
the distance of the human nose to the main branching of the airways In
human lungs. The animal used should be fully described as to age, genetic
background, weight, nutritional state, physical condition, virus oomponents,
extent of surgical tnuma, and the degree of strets to which it is subjected.
Appropriate numbers of both sham-smoked and pgo-held animals should
serve as controls.
The end points sought should Include more than morphological tltera-
tions and the presence or abeence of tumors. For proper Interpretation they
also should include appropriate biochemical ttKasarements and their analy-
sis. Multivariate analysis should then be applied to the data obtained from
the systematic observations of the controlled parameters relative to the
smoking machine, the animal model, and the biological and biochemicxl
measurements.
By these means, it may be possible to develop bioasaay teehniques
related to cigarette smoke. Past experiments, where the sole objective was
the attempt to induce tumors, must be carefully and cautiously Interpreted
in light of today's knowledge.
Suitable Animal Modeli Needtd
There is a gneat need for suitable animal models for inhalation ttndks
related both to lung cancer and chronic respiratory ailments. Pending
development of such models, tests have been designed under Council
support to provide a careful, quantitative, deaeriptire picture of any and
all observable morphological changes in the lungs of mice exposed to whole
cigarette smoke or the gas-vapor phase. These experiments will be analot-
ous in design to those now being completed with oxides of nitrogen, ora+e,
and carbon monoxide.
As regards lung cancer, it wonld be very helpful to have a positive
animal model of the human disease. If sqnamous cell lung amcer---the
type reported to be most common In humans-eould be produced by ttome
t
simple and acceptable procedure and at a repodtscibk level, it could be
possible to plan systematic experiments to determine what added factors
might induce it earlier or delay its appearance. Any such factors found to
contribute to susceptibility or resistance In the animal model could then be
checked in humans. The goal is to obtain clues to the possibiq contributory
influence of many internal and external factors In the animal model and
then see if these are related to the human experirnce In any way.
In addition to sntoking, a great many other factors need to be eva?o-
ated in this way. One is the effect of vitamin deDdeneiea, especially vitamM
A. Another is liver damage, which has already been shown by Council-
9

supported studies to predispose to cancer of the oral cavity. Another is
disturbance of the hormone balance. Another is air pollution. There are
many more.
Development o/.(pparatss and Techniques
The Council has long supported research to develop apparatus and
control methods for smoke inhalation experiments and also to find satis-
factory teehniques of ineasuring lung surface dosages, especially of the
particulate phase of the smoke.
Considerabk progress has been made in development of improved
mechanical equipment for such studies, and several new devices are now
undergoing exacting tests. Feasibility studies have been conducted and it
is expected that there shortly will be initiation of new, long-term inhalation
work combining the use of improved equipment and also of better stand-
ardmed animal substrates. Certain animals, for example, have long been
considered inappropriate for meaningful inhalation experiments.
With the use of presently available and partially improved smoke
exposure devices, scientists working under a grant from The Council
have exposed guinea pigs to short-term, chronic inhalation of whole smoke
in order to observe whether changes would develop in the oxidative enzyme
activity of isolated lung mitochondria. The stress effects of handling and
machine exposure without smoke Inhalation have been assessed in control
animals. These studies are now being extended to longer term exposures and
to inhalation of gas-vaporphase without particulate matter or nicotine.
Motase Skin Paintbsa.nd Lung Cancer
The induction of skin cancer on mice painted with cigarette smoke
eondensate ("tar") has been, and still is in some circles, accepted as
evidence that smoking can contribute to human lung cancer. However,
0 smoke condensate is not whole smoke, the skin Is not like the lung, and
studies supported by The Council have shown that various tissues in the
~ nme animal respond very diffetently to a single chemical carcinogen. The
a oral cavity tissues of mice, for example, are much more resistant to
0 benzo(a)pyrene than their skins.
It must be emphastsed that there is no reliable evidence that the
condensate fraction can produce tumors in the lunga of experimental
animals. Many experiments supported by The Council and by pthers have
failed completely to produce lung tumors when solutions or emulsions of
cigarette smoke condensate were instilled directly into the lungs of ducks,
hamsters and mice. Injectbn of smoke condensate emulsions into the
I
bloodstream of mice and of lung-damaged rats failed to produce lung
tumors, though benzo(a)pyrene emutsions did so under the same tech-
niques. Therefore, there is no reliable evidence that the "tar" fraction of
cigarette smoke acts as a lung earcinogen even in experimental animals.
Yiruses and Canar
A growing field of researih is coocerned with the role of viral factors
in human cancer. It has been known for a long time that viruses are directly
involved in a number of animal cancers.
The Council has sponsored a number of studies which touched In one
way or another upon the possible role of varioas virus Infeetions in the
genesis of cancer. Recent developments In the study of virus-eaneer inter-
relationships, sponsored by other agencies, have produced much evidenee
to support a unifying hypothesis which combines genetk concepts with con-
temporary knowledge of the nature and aetion of virnses.
7liese developments concerning viruses tend to place new and In-
creased emphasis on the condition of thb host In carcinogenesis experiments
and introduce new dimensions and controls into animal test models-
7Tie Council has undertaken to support research connected with the
testing and development of some phases of this virus-cancer theory. At
the same time, it is helping to develop new and better-controlled cell culture
and whole animal models for measuring the Interaction of susceptibility
factors with external stimuli in tumor produetion. Such models, it Is hoped,
will be useful as assay systems for testing the effects of whole, fresh,
normal cigarette smoke or its fractions (particularly the gas-vapor phtae)
or components more realistically than Is possible with cruder methods.
Bladder Cancer
Data relating to bladder anotx In humans are sparse other than those
concerned with occupational factors, where there ia a much clearer picture.
Though several epidemiologipf studies have teported a statistical associa-
tion between cigarette smoking and eaneer of the bladder In human maks,
the question of whether there is a eaasal relatlonrhip remains open. Tbe
findings for females were contradictory, and there were Inconsistent results
of animal experiments with cigarette smoke oondeneate. Vital statistics for
the past 15 years do not show a signifiant rise In reported ear+es of bladder
cancer. Hence, the reported statktical association has lacked rational ex-
planation.
IA~
~ 10 11
O

~
~
rV ~
~
...~. ®
~
.+...
0
0
~ 1i~s
.~.1
In 1965, a hypothesis was advanced to the effect that nicotine might
so disturb the metabofiam of tr7Ptophan as to result in abnormal accumula-
tion of certain normal intermediates related chemically to substances which,
when implanted as pellets in the bladden of mice, were found to produce
cancers in that species. A basic postulate of this th>ory was that bladder
cancer patients generany show a disturbance of tryptophan metabolism
akie to that claimed to occur in smokers.
This hypothesis has been investigated in three different centers as part
of a broad bladder eanaer study that included clinical, pathological, bio-
chemical and experimental aspects. Contrary to the hypothesis, four out
of five bladder cancer patients were found to excrete tryptophan metab-
olites in a normal pattern even after tryptophan loading tests.
In mice, the liberal feeding of vitamin C prevented production of
bladder cancers by Implanted pellets of 3-hydroxyanthraniiic acid, a normal
tryptophan metabolite.
The comparative excretion patterns of nine tryptophan metabolites
by smoking and nonsmoking subjects have also been under investigation
and reports are scheduled for early publication.
As part of its sponsorship o( studies in this field, The Council con-
tributed to the support of a symposium on "The Epidemiology and Etiology
of Human Bladder Caneer," )ointly sponsored by the Cancer Research
Institute of the New England Deaconess Hospital, and the Department of
Pathology, Boston University School of Medicine. The symposium was
held June 6 and 7, 196g, in Boston, and most of the papers presented
were published in the Jotrrnal of The Norional Cancer Institute, 43, 217
(1969).
Cardiovascular Diseases
Cardiovaacular diseases account for more deaths among U.S. males
than any other disease dtegory. The cardiovascular system itself is subject
to a variety of disorders. The reost common of these is arterioeclerosis,
the result of unknown pathological processes that lead to progressive loss
of resiliency of the arterial vesad wall accompanied by increased rigidity
and narrowing of the himen. A common sequel is abrupt occlusion by
thrombosis, and the effects include a faulty supply of blood to a tissue or
own, inadoqwte to meet Its needs. Frequent consequences are common
forms of heart attacks, brain stroke, gangrene of a leg, rupture of the aorta,
and certain kinds of high blood pressure.
T'here are a number of suggested factors in arteriosclerotic diseases
12
including lipid metabolism, vascular connective tksue damage, endocrine
dysfunction, and 6brin depoaits on the re=sel walls. Diet, hypertension,
obesity, lack of exercise, psychological factors (sttess and tension), and
smoking have been mentioned as possible contributors.
Some autopsy studies have reported no association bet..eert smoking
and arteriosclerosis. Others have reported that heavy cigarette smokers
have more extensive lesions of the coror+ary arteries than do light or
nonsmokers. Theae data are limited in quantity. The lesions reported also
require further study to determine it they differ In quality or pathogenesis
between smokers and nonsmokers, t+ince smoking has not been demon-
strated to have an etiologic significance.
Dietary cholesterol has been cited by many as perhaps the maior
factor in heart disease. Hypertension appean to run second in impottance,
according to some investigators. There have been reports claiming a rela-
tionship between smoking and hypertension but, paradoxically, it has been
found that men who are heavy cigarette smokers generally have lower
blood pressures than nonsmokers.
It is obvious that the situation, in general, Is complex and obscure.
Twin Studies in 1lemn Disease
Twin studies conducted both In this country ad abroad under other
auspices have cast doubt on smoking as a cause of heart disease. These
studies help to emphasize (by their control of factors which would other-
wise vary between smokers and nonsmokers) the Importance of not only
continued work with twins but of multivarlate analysis. If smoking twins
have no higher mortality than nonsmoking twins (as Indicated by pre-
liminary liminary reports), such a finding emphaaizes the need for caution in
evaluating uncontrolled statbtical studies.
With support from The Council for Tobacco Research, two ocientists
undertook a study of the effects of environmental factors on the develop-
ment of atherosclerosis as reveakd by autopsy of accident victims. Their
work, with support from other sources, was later extended to be included
in the International Atherosclerosis Projcct.
These investigators found fatty sttraks In almost all the aortas of
boys and girls aged 10-14 and similar streaks In the coronary arteries of
most persons aged 20-29. The streaks are dinically harmless and poten-
tially reversible, they noted. However, they said atherosclerotic lesions
may appear in the coronary arteries before the age of 20 and that the
conversion of fatty streaks to 6brous plaques occurs at an earlier age In
populations with high coronary heart disease morbidity and mortality.
13

Nicotine: Psycho-Pharmacological
and Behavioral Effects
Soerc of the bases for human use of tobacco are certainly to be found
in social or psyehological needs. However, on the assumption that others
might also be found in the realm of psycho-pharmacology, that is, in the
effects of smoking and/or nicotine on the central nervous system, The
Council has supported a number of studies in this field. several of which
have been summarized in previous Reports.
The volume of this work reached a level deemed to justify a public
symposium on "The Effects of Nicotine and Smoking on the Central Ner-
vous System" which was sponsored jointly by The Council and the New
York Academy of Sciences on April 7-9. 1966, and published by the
Academy in March 1967. Crantees of The Council participated in the
sessiort as did a considerable number of other independent investigators
from the United States and abroad.
Work reported at the symposium established that nicotine does defi-
nitely pass the blood brain barrier and affects brain activity as shown by
ekdroencephabgaphic ttscings both in animals and in man. Because of
the rapWrty of these brain wave changes, it was postulated that smoke may
also stimulate nerv e endittµ in the lungs to send signals to the brain.
The effects of nicotine on the brain are not always the same. Depend-
ing on the state of the eervous system and on the dosage, an "arousaP" or
"S.ako-up" effect may ooaa which Is reflected both in brain waves and in
behavior. This effect k aceotnpiished by a dilation of the pupila and a slight
rise In blood pressure. Confirmation that this was due to nicotine came
from experiments involving direct instillation of the alkaloid into the brains
of animals.
n In larger doses or In a diRerent state of the nervous system, a peculiar
~ steady state of longer daration is produced which may be described as
.~'U intermedtate betwoen alertness and sleep. This has been described as a
S "tranqnilizer effect"
These f3ndings eonffrnt the subjective reports of cigarette smokers.
Extension of the eki.troencephalographic studies to human subjects
has produced some observatious that appear relevant to the question why
sontre persons need or want to smoke while others do not. lt was found
that the prevailing encephdographic patterns of nonsmokers differ mark-
edly from those of smokers or persons who had never been smokers, even
~ long atter discontinuance of the habit. A marked difference in the ability to
produce the "alpha" pattern by consdous effort also existed between these
groups
Since long discontinuance of smoking by former heavy amokets did not
alter these relationships, it was postulated that the difference in prevailing
brain wave patterns has a congenital basis aod may explain the function
of smoking to modify or "normalize" central nervous system activity.
If this finding is confirmed, it will itdisxte that smokers and noe-
smokers may have important basic eatstitational differences which also
may produce differences In their predisposition to the development of cer-
tain diseases, especially those of a"paychosomatic" nature. Since predis-
position to cardiovascular disease has been attributed to difterences In
psychological or personality type, it becomes Important to investigate
poss;ble correlations between types as defined by a psychological test and
as distinguished by encephalography.
Besides these effects, it was reported at the symposiam that small
doses of nicotine have a favorable effect on the learning process in both
rats and some other animals when they are made to petform certain actions
to receive a reward or to avoid a discomforting experience such as electric
shock. Several ramifications of this basic finding have been putstsed further
and certain pharmacolosical mechanisms were elucidated In some cases.
Chronic Respiratory Diseases
The Scientific Advisory Board has long been aware of the need tor
research into chronic respiratory dfseaaes am has awarded many graets
in this field. There is a reported inerease in ttoch d'nea~es as eames of
illness and death but whether there has been any comparable true tnctesae
remains questionable.
'I'here is reason to believe, in any ereat, on the basis of t+eseasch
findings, that one important factor in any reported Increase Is the te:<ne,
particularly with the use of antibiotics, of many persons from death due to
severe lung infectioru. They then live on with damaged lungs to develop
chronic respiratory ailments later In life.
The possible influence of cigarette smohing on the causation or ex-
accrbation of chronic respiratory diseases is dit19cu1t to assess. One of the
difficulties is the inability to distinguish adequately between chronic bron-
chitis and emphysema. Both eonditions are often found to co-exist in many
patients.
The aozurate classification and recognition of emphysema by the
t,0
iS
14

medical pr ~an have really not advanced very far. For e:ample, de-
trompensation in chronic pulmonary disease and cardiac abnormalities are
not yet .eevrately distingunhabk.
Stmederdi.sed Techniqacos Needed
Fmther, standardized techniques are needed to compare the prevalence
of emphysema in different societies or different eountries, an approach
that is long overdue. Suitable morpho#ogk criteria for properly classifying,
quantitating and evaluating emphysema have barely begun to emerge in
the past five years. The necessary techniques are now used only in a few
institutiorn. Even fixation of lungs ia the expanded state, the essential first
step in establishing the presence, type and degroe o( emphysemi, is rarely
pr2cliced.
Death reported from emphysema eattnot.praently be defined with
any accuracy as to what actual pathologic conditions may be present. No
tmdormly applied, scienti8eally sound clinical methods are now in general
use whereby emphysema can be identified and quantitated.
The basic knowkdae and even the definition of chronic bronchitis are
still lacking despite some recent notable contributions. Beyond the need to
standardize, and even more to find better dinical and pathologic diagnostic
criteria for chronic bronchitis, there are also problems of its possible rela-
tion to repeated viral and bacterial infectioro over a lifetime, particulate
and nortpartievlate irritattts, aEjna, changes in the bronchial mucosa, and
hyperseraitivity diseases.
The Council has supported pioneering studies to describe anatomic
emphysema more quantitatively and to dilfersntiate among the several dis-
tingtsishable types. ft has also spoesored number of clinical studies of
pulmotfary faection, for description of short-term effects of inhaled agents.
h+e1 a Ent tobacco smok0. In subjects of various aaes and in various condi-
tions. These have been described from time to time in earlier Annual
RePaft
More receady, The ConnciJ provided support for a study of the
siblings of dxoeic rapirNory patleata. The siblings and the patients were
the test goup and their spouses served aa a control group. This investiga-
tbn revealed the eatistence of a familial tendency to functional impairment
d the ha+sa.
Otha imestigatfotn tsave'oootfttrted to the present impressive evi-
deoce that certain genetic tatzytnts deflchncies (alpha; antitrypsin) strongly
pred'rspoae to empi+ysema W honfaxytotea carrying this gene and that even
a7E~a may show in enhanced degree of preedisposition.
In-Depth Cfiniea! Stndlea Under lt'ay
The Council has recently provided svpptxt for major long-term, In-
depth clinical studies of chronic respiratory dbatse entities ih two geo-
graphically separated urban oenters. A third cihsic that spedalisa ht lunt
function tncasurements of youna ehildree has more recently been added to
the projeet.
The hope is that long-term repetitive esaminatlom of patients txr+
provide comprehensive information oe personal eMracteri:ties, family his-
tory, manner of 1ife, envinonmeMal exposures (Including tobacco smoking),
contributory infections, tespone to treatment and eoane of the disease.
The extensive clinical and laboratory data oompiled by the inrestigattors
may produce better definitions d the various clinical entities and motr
reliable methods of differential diagnotis.
It seems obvious that such de9nitions and diagnosis are absolute
prerequisites to any real progress in the study of the etiology of chronic
puimonary diseases in terms of the interplay of intrinsic and extrinsic
factors.
16 17

Abstracts of Reports
Each recipient of a grant-in-aid from The Council for Tobacco Re-
search -U.S.A. is responsible for the initial presentation or publication of
the rcsults of his resear+ch at scientific meetings or in appropnate scientific
journals.
Following are abatracts, approved by the authora, of reports on new
~ptt'+~+t~ ~h acktw..fea$mg support from The Council that have
appeared in seientifie journals sincepu blicatioo of the 1966-67 Report of
the Scientific Director. The name of the grantee is in italics.
71>he abstncts have been grouped under these hcadin&i: 1. Psycho-
Physiological Studies, 11. CGreinogtnesis Studies, Ill. Cardiovascular Sys-
tem. IV. Respiratory System, V. Neurophytiology, VI. Studies at the Cellular
Level, VII. Cell and Tasue Culture, Vlll. Epidemiology, IX. Pharmacology
and Psycho-Pharmacology, X. Metaboiic Studies, Xl. Chemistry and Bio-
chemistry, XII. Other Studies, and XIII. Reviews.
I. Ptycho-Phyitologioat Studiea
ALTERATIONS IN THE BEHAVIORAL AND BIOCIfEMICAL
FfFECTS OF ELECTROGbNVULSIVE SHOCK WITH NICOTINE Electrocon right after coodtt' i~ooed-reapoc e
triini producest a~ retrograde amnesic
e$eCL In experiments wrhere mice were pretreated with nicotine sulfate,
this amnesic rtsponre to sbocY was aigni&antly blocked by the drug. The
attenuation of the tetrogtade amnesia was particularly spparent when drug
treatment was giren 45 to 60 minutes prior to training. The high incidence
of conditioned respoese r tentbn In drug-truted mice was paralleled by a
reversal of the predicted effect of ECS upon brain serotonin levels. While
the celatiooehi~ betweea EGS-induced elevation in whole brain serotonin
level and ECS-itdueed tetrogtade amnesia is not necesaanlq causal, the
niootine-indaced reversal In both asns of the cvstomary ECS effects sug-
~possibie eacallaqr of the drug-induced facilitation of memory con-
Fssntan, W. B., Steinbert, M. L. and Golod, M. 1.
Pt7chononrkScknce 12(3):1U7-10g, 1968.
OrM+r Rrw.torr Natlonal Institutes of Hcalth.
From the Department of "oSy, Queens College of the City University
of New York, Fluahing, N Y.
TASTE THRESHOLDS IN TWINS AND SIBLINGS
Taste thresholds for hydrochlork acM, quinine, and 6-n-propylthiours-
cil (PROP) were detennMed in pain of tnonozygotic (MZ) twins, dizygotic
(DZ) twins, and siblings (SiB). The numbets of pain Involved were 75
MZ, 70 DZ, and 78 SIB, for the latter two compounds; 26, 45, and 45,
respectively, for the acid. Significant differenas in intrapair variance were
found (1) between the MZ and the saroe-aex DZ pairs In thresholds for
bitter-tasting PROP, and (2) between the male MZ pain and the male DZ
or male SIB pairs for hydrochloric acid. The digtxenee in intrapair thres-
hold variance was not significant for bitter-tastin= quinine. Intrapair differ-
ences observed in the MZ twins indicate that nottgenetk factors also inffn-
ence taste thresholds. Drugs, smoking, and the met>sttoat cycle are atttong
the environmental factors that may affect taste thresholds. Other obserra-
tions showed that, with all three compottnds, repeated taste tests on the
same subjects yielded high numbers of results sind ar,within a single thresh-
old range. Also, in 308 subjects, correlations between thresholds for the
dilferent substances were positive and significant
Koplan, A. R., Fisher, R., Karras, A.. Oriffin, F., Powell, W., Marsters,
R. W. and Glanville, E. V.
Acre Geneficnt Mrdicoe tr Ctmeffoloaioe 16(3 ):229-244, 1967.
Other Rrantorr National Institutes of Htxltlt.
From the Department of Genetim Cleveland Psychtatrie Institute, Cle.c-
tand.
PHYSIOLOGICAL AND PATHOLOGICAL CORRELATES OF
DIFFERENCES IN TASTE ACUITY
The effects of various parameters (geeetica, dietiry prcfermcese ase,
sex, smoking, biological acuity, personallty, menstruation, duodend ulcers.
and gastric ulcers) upon taste acvit7 are surveyed in this report When
monozygotic (MZ) twins, diry t..ins (DZ), and non-twin sibling (SIB)
pairs were tested for intrapair differences o( taste thresholds, it was seen that
the intrapair differences in the MZ pairs wett aigni8eantly 1as than In
either the DZ or SIB n. In other atudiea, sensitive tasters of quinine and
6-n-propylthiouracil (PROP) reported relatively larp numbers of food
dislikes and a preference tor ndld-tsstin= foods, compared to Imetssltire
tasters. The sensitive tasters Included a relativellr~h~ proportloo o[ non-
smokera, compared to the insensitive tasters, who itxtoded a relativelr high
proportion of heavy smokers. Taste threshold was not found to be related
to age or sex when smoking habits were exptximentally controlltd, but
heavy smokers were observed to manifest decttased taste sensitidty with
increascd age. Phases of the menstrualcytk were aolrntimes associated with
significant changes In taste thresholds. Ap}arentty, high taste sensitivity for
both quinine and PROP may be assodatod with high feneral systetnic re-
activity, and vice versa. There tdaosppears to be a possible association with
personality differences. Individual differences In htte acuity patterns, re-
lated to both genetic and noegenetic variables, have also been associated
with significant differences in peptic uleer pathology. Duodenal uFcerpa-
tients, as a group, were signiflcantly more sensitive to the taste of PROP.
but not of quinine or hydrochloric atid, than cther gastric ulcer patients
or nonpatient controls.
I8 19
